Skip to content

RINGFARMA

Active Public limited companyfounded 1992active for 34 yearsRomeinsesteenweg 450-452, 1853 GrimbergenKBO/BCE: BE 0448.348.252 subsidiary of GDK FARMA

Board

1 director, 1 in day-to-day management, last change in 2024
Sole director and managing director, permanent representative Yves DE DECKER
appointed by deed of 15-03-2024
earlier director, until 15-03-2024
listed in the 2025 annual accounts, filed on 29-06-2026
GDK FARMA
Permanent representatives 1
Yves DE DECKER
Permanent representative, for GDK FARMA
appointed by deed of 15-03-2024

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
GDK FARMA
Sole director, Managing director
LeadershipBoardEarliermandate already running before its first mention
Mandates as a list
  • GDK FARMA
    • Sole director, since before 31-12-2021
    • Director, until 15-03-2024
    • Managing director, appointed by deed of 15-03-2024, still in office

Control

Parent
Equity €3.0m
Loss €339,047 in 2025
Checked score 82
99.8%
This company
RINGFARMA
Equity €84,128
Profit €6,194 in 2025

Capital

Capital
€123,946.76
Shares
500
Contribution per share
€248
Equity per share
€168 in 2025
Source
deed of 15-03-2024

Owners through the years

as the annual accounts name them
Owners as a list

Source: lists of holdings in the owners' accounts

Articles of association

deed of 15-03-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
“Artikel 4. Duur De vennootschap is opgericht voor een onbepaalde duur.”
Board ruleThese rules set how the board is made up, meets and takes decisions.
Term of at most 6 years
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
15 June at 16:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Alle verrichtingen vermeld in de wet, tenzij algemene vergadering anders besluit bij gewone meerderheid”

Next steps